摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

R-(-)-7-Methyl-5,6,7,8-tetrahydroimidazo<1,5-c>pyrimidin-5-on | 76311-37-0

中文名称
——
中文别名
——
英文名称
R-(-)-7-Methyl-5,6,7,8-tetrahydroimidazo<1,5-c>pyrimidin-5-on
英文别名
(7R)-7-methyl-7,8-dihydro-6H-imidazo[1,5-c]pyrimidin-5-one
R-(-)-7-Methyl-5,6,7,8-tetrahydroimidazo<1,5-c>pyrimidin-5-on化学式
CAS
76311-37-0
化学式
C7H9N3O
mdl
——
分子量
151.168
InChiKey
ZEGMPIVEGUFNGD-RXMQYKEDSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    0.2
  • 重原子数:
    11
  • 可旋转键数:
    0
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.43
  • 拓扑面积:
    46.9
  • 氢给体数:
    1
  • 氢受体数:
    2

反应信息

  • 作为反应物:
    描述:
    R-(-)-7-Methyl-5,6,7,8-tetrahydroimidazo<1,5-c>pyrimidin-5-on氢碘酸 作用下, 以 N,N-二甲基甲酰胺 为溶剂, 反应 17.0h, 生成 (R)-(-)-1-(1-methyl-1H-imidazol-4-yl)-2-propanamine dihydroiodide
    参考文献:
    名称:
    Synthesis and histamine H3-receptor agonist activity of mono- and dialkyl-substituted histamine derivatives
    摘要:
    In search for potential histamine H-3-receptor agonists a series of mono- and dialkyl-substituted histamine derivatives was synthesized. All target compounds were tested in vitro for their agonist activity at H-3-, H-2-, and H-1-receptors. Introduction of one ethyl or two methyl residues into histamine led to compounds with decreased histamine H-3-agonist potency in most cases. However, the non-chiral alpha,alpha-dimethylhistamine (15) was identified to be three times as active as histamine itself at H-3-receptors. In addition 15 Dimethylhistamine 23, which is a potential metabolite of (alpha R)-alpha-methylhistamine 1, proved to be inactive at all three histamine receptor subtypes.
    DOI:
    10.1016/0223-5234(96)88228-6
  • 作为产物:
    描述:
    (R)-α-methylhistamine dihydrochloride 、 N,N'-羰基二咪唑sodium ethanolate 作用下, 反应 1.0h, 以60%的产率得到R-(-)-7-Methyl-5,6,7,8-tetrahydroimidazo<1,5-c>pyrimidin-5-on
    参考文献:
    名称:
    组胺类似物的构效关系,22. Mitt. 对映体 α, Nα-二甲基组胺的绝对构型和组胺样效应
    摘要:
    对映体 α, Nα-二甲基组胺 (+) - 3 和 (-) - 3 的合成,绝对构型的推导和对映体在回肠 (H1) 和心房 (H2) 上的组胺样活性豚鼠进行了描述。
    DOI:
    10.1002/ardp.19803130909
点击查看最新优质反应信息

同类化合物

脱氧助间型霉素 叔-丁基3-溴-8,9-二氢-5H-咪唑并[1,2-D][1,4]二氮杂卓-7(6H)-甲酸基酯 化合物RK-33 8-叔-丁基1-乙基6,7-二氢-5H-咪唑并[1,5-A][1,4]二氮杂卓-1,8(9H)-二甲酸基酯 8-(叔丁氧羰基)-6,7,8,9-四氢-5H-咪唑并[1,5-A][1,4]二氮杂-1-羧酸 6-羟基-4,5,6,7-四氢咪唑并[4,5-e][1,4]二氮杂卓-8(1H)-酮 5-(8-羟基-7,8-二氢-4H-咪唑并[5,4-d][1,3]二氮杂卓-3-基)-3-(羟基甲基)环戊-3-烯-1,2-二醇 4,7-二氢咪唑并[4,5-d][1,3]二氮杂卓-8(1H)-酮 3-[(2-羟基乙氧基)甲基]-3,4,7,8-四氢咪唑并[4,5-d][1,3]二氮杂卓-8-醇 1H-咪唑并[1,5-d〕〔1,4]二氮杂(9CI) 1,4,6,7-四氢咪唑并[4,5-e][1,4]二氮杂卓-5,8-二酮 (9ci)-1H-咪唑并[1,2-a][1,4]二氮杂卓 9H-imidazo[2,1-i]purin-8-one 3-(2-chlorobenzyl)-7-(4-methoxybenzyl)-3,7-dihydro-2H-diimidazo[4,5-d:4',5'-f][1,3]diazepin-2-one R-(-)-7-Methyl-5,6,7,8-tetrahydroimidazo<1,5-c>pyrimidin-5-on benzyl N-[(23R,52R)-52-amino-5,11,17,28,34,40,46,57-octamethyl-3,9,15,21,26,32,38,44,50,55-decaoxo-2,5,8,11,14,17,20,25,28,31,34,37,40,43,46,49,54,57,60,64-icosazanonacyclo[54.2.1.14,7.110,13.116,19.127,30.133,36.139,42.145,48]hexahexaconta-1(58),4(66),6,10(65),12,16(64),18,27(63),29,33(62),35,39(61),41,45(60),47,56(59)-hexadecaen-23-yl]carbamate tert-butyl (1-(1-(but-2-yn-1-yl)-4-methyl-7-oxo-6,7-dihydro-1H-imidazo[4,5-d]pyridazin-2-yl)piperidin-3-yl)carbamate 14-(7-(bromomethyl)-1H-imidazo[4,5-c]pyridin-4-yl)-14-azadispiro[5.0.57.36]pentadecane-13,15-dione cyclo-(-ImPyPyPy-(R)β-NHCbzγ-ImPyPyPy-(R)β-NHCbzγ-) benzyl N-[(23R,52R)-23-amino-5,11,17,28,34,40,46,57-octamethyl-3,9,15,21,26,32,38,44,50,55-decaoxo-2,5,8,11,14,17,20,25,28,31,34,37,40,43,46,49,54,57,60,61,64-henicosazanonacyclo[54.2.1.14,7.110,13.116,19.127,30.133,36.139,42.145,48]hexahexaconta-1(58),4(66),6,10(65),12,16(64),18,27(63),29,33(62),35,39(61),41,45(60),47,56(59)-hexadecaen-52-yl]carbamate 2-tert-butyldimethylsilyl-5-[(1S,2S)-2-dibenzylamino-1,4-dihydroxybutyl]-N,N-dimethylimidazole-1-sulfonamide 4-[7-(2-methyl-1H-benzimidazol-6-yl)-2,3-dihydro-1,4-benzoxazepin-4(5H)-yl]-6,7,8,9-tetrahydropyrimido[4,5-b]indolizine-10-carbonitrile benzyl N-[(23R,52R)-52-amino-5,11,17,28,34,40,46,57-octamethyl-3,9,15,21,26,32,38,44,50,55-decaoxo-2,5,8,11,14,17,20,25,28,31,34,37,40,43,46,49,54,57,60,61,64-henicosazanonacyclo[54.2.1.14,7.110,13.116,19.127,30.133,36.139,42.145,48]hexahexaconta-1(58),4(66),6,10(65),12,16(64),18,27(63),29,33(62),35,39(61),41,45(60),47,56(59)-hexadecaen-23-yl]carbamate (8R)-3-(p-Methoxybenzyl)-8-<(tert-butyldimethylsilyl)oxy>-3,6,7,8-tetrahydroimidazo<4,5-d><1,3>diazepine 8H-Pyrazino[1,2-a]pyrimidine-8-carboxylic acid, 2-(2-aminoethyl)-4,6,7,9-tetrahydro-4-oxo-, 1,1-dimethylethyl ester 3,4,6,7-Tetrahydro-7-methyl-4-propylimidazo[4,5-e][1,4]diazepine-5,8-dione 1-methyl-1,2,3,4-tetrahydropyrido<3',2':4,5>imidazo<1,2-a>pyrimidin-2-one 5-(4H-1-piperazinyl)-11H-imidazo[1,2-c][1,3]benzodiazepine hydrobromide tert-butyl 7-(4-(benzyloxy)-2-oxopyridin-1(2H)-yl)-3,4-dihydropyrido[4',3':4,5]imidazo[1,2-a]pyridine-2(1H)-carboxylate N-(7H-Imidazo<1,5c><1,3>diazepin-5(6H)-yliden)-N'-<2-<(5-methyl-1H-imidazol-4-yl)methylthio>ethyl>harnstoff 1,2-Dimethyl-4,5,6,7-tetrahydro-1H-imidazo[4,5-e][1,4]diazepin-8-one 1-benzyl-5-hydroxy-4,5,6,7-tetrahydroimidazo<4,5-e><1,4>diazepin-8(1H)-one [5-(8-Hydroxy-7,8-dihydro-6H-imidazo[4,5-d][1,3]diazepin-3-yl)-pentyl]-phosphonic acid dibenzyl ester 6,7-dihydro-3-<(2-hydroxyethoxy)methyl>imidazo<4,5-d><1,3>diazepin-8(3H)-one 4-chloro-8,9-dihydro-7H-pyrimido[4,5-b]azepine-6-carboxylic acid monohydrochloride 1,6-dimethyl-1,4,6,7-tetrahydro-imidazo[4,5-b]pyridin-5-one 1-Benzyl-7,8-dihydro-1H,5H-imidazo<4,5-e><1,3>diazepine-4,6-dione methyl5H,6H,7H,8H,9H-imidazo[1,2-a][1,4]diazepine-6-carboxylatedihydrochloride 3-(2,4-difluorophenyl)-7-(4-methoxybenzyl)-3,7-dihydro-2H-diimidazo[4,5-d:4',5'-f][1,3]diazepin-2-one 3-(3,5-dimethyl-cyclohexyl)-1-methyl-6-methylsulfanyl-1H-[1,3,5]triazine-2,4-dione 3-{5-[2-(2-Trimethylsilanyl-ethoxymethyl)-2H-tetrazol-5-yl]-pentyl}-3,6,7,8-tetrahydro-imidazo[4,5-d][1,3]diazepin-8-ol N-{4-[(8-cyclohexyl-2,8-diazaspiro[4.5]dec-2-yl)methyl]benzyl}-2-(1H-imidazol-4-yl)-N-(1H-imidazol-2-ylmethyl)ethanamine 4-Fluoro-3-[2-(8-hydroxy-7,8-dihydro-6H-imidazo[4,5-d][1,3]diazepin-3-yl)-ethyl]-benzoic acid methyl ester (8S)-3-(2-deoxy-β-D-erythro-pentofuranosyl)-3,6,7,8-tetrahydro-5-methylimidazo<4,5-d><1,3>diazepin-8-ol 6,7-dihydro-3-<<2-(p-toluoyloxy)ethoxy>methyl>imidazo<4,5-d><1,3>diazepin-8(3H)-one 3,4-dibenzyl-4,5,7,8-tetrahydro-6-hydroxy-6H-imidazo[4,5-e][1,4]diazepine-5,8-dione